Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 22;11(2):100364.
doi: 10.1016/j.apjon.2023.100364. eCollection 2024 Feb.

Symptom experience in endocrine therapy for breast cancer patients: A qualitative systematic review and meta-synthesis

Yan Ma  1   2 , Zhenqi Lu  1   2 , Jiajia Qiu  1   2 , Huiyu Luo  3 , Lichen Tang  4 , Yun Li  1   2 , Ping Li  1   2
Affiliations
Review

Symptom experience in endocrine therapy for breast cancer patients: A qualitative systematic review and meta-synthesis

Yan Ma et al. Asia Pac J Oncol Nurs. .

Abstract

Objective: The purpose of this study was to systematically integrate the experience of symptoms of breast cancer patients receiving endocrine therapy, analyze the patients' understanding and coping status of symptoms, and provide information for the development of targeted symptom management measures.

Methods: We searched databases including PubMed/MEDLINE, MEDLINE (Ovid), Web of Science, EMBASE (Ovid), CINAHL (EBSCO), and ProQuest from inception to September 25, 2023. Literature was screened and analyzed using Endnote software, evaluated using the Joanna Briggs Institute Critical Appraisal Tool for Qualitative Research, and the results were integrated using JBI's Pooled Integration Methodology.

Results: Three composite findings were derived from 10 studies: symptom distress during endocrine therapy; coping in symptom experience; and support needs.

Conclusions: Emphasis should be placed on the symptomatic experience of breast cancer patients undergoing endocrine therapy, and effective interventions should be developed to improve patients' medication compliance and quality of life. Finally, the long-term survival rate of patients is improved.

Systematic review registration: CRD42023466073.

Keywords: Breast cancer; Endocrine therapy; Meta synthesis; Qualitative research; Symptoms; Systematic review.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA for diagram of the selection process. PRISMA, preferred reporting items for systematic reviews and meta-analyses.
See this image and copyright information in PMC

References

    1. Giaquinto A.N., Sung H., Miller K.D., et al. Breast cancer statistics, 2022. CA-A Cancer J Clin. 2022;72(6):524–541. - PubMed
    1. Burstein H.J., Lacchetti C., Griggs J.J. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Oncol Pract. 2019;15(2):106–+. - PubMed
    1. ASSOCIATION B C C O C A-C Chinese anti-Cancer Association guidelines and specifications for the diagnosis and treatment of breast cancer (2021 edition) Chin J Cancer. 2021;31(10):954–1040.
    1. Gan J., Liang T., Jiang T., et al. Progress in the study of symptom burden in patients with endocrine therapy for breast cancer. J Adv Nurs. 2022;37(22):2059–2065.
    1. Sebaoun P., Frederic M., Weryha G., et al. Tolerance of Tamoxifen as an adjuvant therapy and long-term follow up of 55 premenopausal breast cancer women, cared for at the Institut de cancérologie de Lorraine, treated with Tamoxifen. Bulletin du Cancer. 2019;106(12S1):S75–S100. - PubMed

LinkOut - more resources